0 NASDAQ Companies - November 11, 2024Pennant Group to Participate in the 2024 Stephens Annual Investment ConferenceEAGLE, Idaho, Nov. 11, 2024 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant […]Read More
0 NASDAQ Companies - November 11, 2024Grab Reports Third Quarter 2024 ResultsRevenue grew 17% year-over-year, or 20% on a constant currency basis to $716 million On-Demand GMV grew 15% year-over-year, or […]Read More
0 NASDAQ Companies - November 11, 2024Stryve Foods, Inc. Announces Timing of Fiscal 2024 Third Quarter ResultsPLANO, Texas, Nov. 11, 2024 (GLOBE NEWSWIRE) — Stryve Foods, Inc. (“Stryve” or “the Company”) (NASDAQ: SNAX), an emerging healthy […]Read More
0 NASDAQ Companies - November 11, 2024Gentherm Announces Updated Fireside Chat Time for 2024 Baird Global Industrial ConferenceNORTHVILLE, Mich., Nov. 11, 2024 (GLOBE NEWSWIRE) — Gentherm (NASDAQ: THRM), the global market leader of innovative thermal management and pneumatic […]Read More
0 NASDAQ Companies - November 11, 2024MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-NovartisLA JOLLA, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market […]Read More
0 NASDAQ Companies - November 11, 2024NEXGEL Announces $2,000,000 Registered Direct OfferingLANGHORNE, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) — NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of […]Read More
0 NASDAQ Companies - November 11, 202423andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the FutureReduces workforce by roughly 40%; expects annualized cost savings of more than $35 million Discontinues development of therapeutics division and […]Read More
0 NASDAQ Companies - November 11, 2024Enstar Agrees ADC Agreement with James RiverHAMILTON, Bermuda, Nov. 11, 2024 (GLOBE NEWSWIRE) — Enstar Group Limited (“Enstar”) (Nasdaq: ESGR) announced today that one of its […]Read More
0 NASDAQ Companies - November 11, 2024Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee OsteoarthritisCANTON, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on […]Read More
0 NASDAQ Companies - November 11, 2024Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual MeetingData show that the NPCCSS swallow score reflects the patient’s level of dysfunction Study indicates that a change in score reflects actual […]Read More